Associations of circulating adipokines and coronary artery disease in young adults
Open Access
- 29 May 2024
- journal article
- research article
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 23 (5) , 3965
Abstract
Aim.To evaluate the associations of abdominal obesity (AO), adipokines and premature coronary artery disease (CAD) in young people for a deeper understanding of the pathogenesis of atherosclerotic diseases.Material and methods.A total of 1457 people were examined, including 653 (44,8%) men. Mean age was 36,7±6,0 years. Premature CAD was detected in 46 people, while 4 following subgroups were formed (138 people in total): with CAD and AO; with CAD, without AO; control groups by age and sex: without CAD, with AO; without CAD, without AO.Results.Premature CAD in young people is associated with an increase in non-high-density lipoprotein cholesterol (non-HDL-C). Univariate analysis found that the probability of CAD increased by 1% with an increase in adiponectin level, and by 0,2% with an increase of 1 ng/ml in resistin level. Multivariate regression analysis, including sex, age, waist circumference, non-HD-C, adiponectin, and resistin, significant associations were obtained for non-HDL-C and adiponectin. With AO, the CAD probability increased by 0,6% with an increase in plasminogen activator inhibitor-1 level (PAI-1). However, when non-HDL-C was included in the model, significance for this biomarker was not achieved.Conclusion.In young people, CAD is associated with increased levels of non-HDL cholesterol, adiponectin, resistin and PAI-1. Independent associations with premature CAD were obtained only for adiponectin, which makes this marker promising for study in young people.Keywords
This publication has 26 references indexed in Scilit:
- Prognostic value of adiponectin level in patients with coronary artery disease: a systematic review and meta-analysisLipids in Health and Disease, 2019
- Long-Term Association of Low-Density Lipoprotein Cholesterol With Cardiovascular Mortality in Individuals at Low 10-Year Risk of Atherosclerotic Cardiovascular DiseaseCirculation, 2018
- Emerging Roles for Adipose Tissue in Cardiovascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2018
- Cardiovascular risk of adipokines: a reviewJournal of International Medical Research, 2017
- Degree of obesity influences the relationship of PAI-1 with body fat distribution and metabolic variables in African womenThrombosis Research, 2016
- EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countriesEuropean Journal of Preventive Cardiology, 2015
- Adipokines in inflammation and metabolic diseaseNature Reviews Immunology, 2011
- Relationships of PAI-1 levels to central obesity and liver steatosis in a sample of adult male population in southern ItalyInternal and Emergency Medicine, 2009
- Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries.Proceedings of the National Academy of Sciences of the United States of America, 1992
- Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1Metabolism, 1990